PROVIDER PROFILE · NPI 1205875143
Meseret Teferra
MEDICARE UTILIZATION · PART B · 2024
No data available for this provider in 2024.
PRESCRIBING · PART D · 2024
Total Rx claims
5,136
Beneficiaries
—
Total drug cost
$270K
Distinct drugs
91
Brand share
20.4%
Top prescribed drugs
Atorvastatin Calcium390 claims
Amlodipine Besylate328 claims
Gabapentin229 claims
Omeprazole201 claims
Montelukast Sodium153 claims
FACILITY AFFILIATIONS
Hospital & Facility Affiliations (3)
CROSS-REFERENCE